The clinical trial data backs this up
Public label data describes a GLP-1 receptor agonist with C187H291N45O59 formula, 4113.58 g/mol molecular weight, albumin-binding protraction through a position-26 lysine modification with a spacer and C18 fatty di-acid, and stabilization against DPP-4 degradation
Most studies have found a decrease in GLP-1 secretion in obese individuals [92], and some studies have found no difference in GLP-1 levels between obese and normal-weight controls [93]
Across TikTok and Reddit , users describe cracking, loosening, increased sensitivity , and even tooth loss , symptoms not typically associated with antidiabetic drugs
While it is unlikely to become toxic, it may become sub-potent. This means the 7mg or 14mg dose you are taking might only have the strength of a much smaller dose
circSamd4 and circMdc1 play a role in positively and negatively regulating cardiomyocyte proliferation by localizing in the mitochondria and regulating ROS and DDR, respectively (101, 102)